Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4421067 | 0.99 | LMNA (0.50) | TSHRTP53CYP3A4MAPK1MEN1 | |
| SCHEMBL15610 | 0.99 | LMNA (0.50) | TSHRTP53CYP3A4MAPK1MEN1 | |
| SCHEMBL8872482 | 0.99 | LMNA (0.50) | TSHRTP53CYP3A4MAPK1MEN1 | |
| SCHEMBL8872228 | 0.99 | LMNA (0.50) | TSHRTP53CYP3A4MAPK1MEN1 | |
| SCHEMBL4629242 | 0.99 | LMNA (0.50) | TSHRTP53CYP3A4MAPK1MEN1 | |
| SCHEMBL6674757 | 0.99 | LMNA (0.50) | TSHRTP53CYP3A4MAPK1MEN1 | |
| Alcohol SCHEMBL27701846 | 0.96 | LMNA (0.48) | TSHRTP53CYP3A4MAPK1MEN1 | |
| Acetic Acid SCHEMBL28691928 | 0.96 | TSHR (0.48) | TSHRTP53CYP3A4MAPK1MEN1 | |
| SCHEMBL1614878 | 0.96 | KDM4E (0.51) | TSHRTP53CYP3A4MAPK1MEN1 | |
| Cetostearyl Alcohol SCHEMBL27567711 | 0.94 | ALDH1A1 (0.46) | TSHRTP53CYP3A4MAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1021161-B1 | USE OF ELLAGIC ACID AND ITS DERIVATIVES IN COSMETICS AND DERMATOLOGY | LVMH RECH (FR) | 2003-01-08 | — | — | EP | claimed |
| US-20020098213-A1 | USE OF ELLAGIC ACID AND ITS DERIVATIVES IN COSMETICS AND DERMATOLOGY | LVMH RECHERCHE (FR) | 2002-07-25 | — | — | US | claimed |
| US-7691806-B2 | Repeat sequence protein polymer active agent congjugates, methods and uses | GENENCOR INTERNATIONAL, INC. (US) | 2010-04-06 | — | — | US | disclosed |
| EP-1633382-A4 | REPEAT SEQUENCE PROTEIN POLYMER ACTIVE AGENT CONJUGATES, METHODS AND USES | DOW CORNING (US) | 2009-08-05 | — | — | EP | disclosed |
| EP-1838428-A1 | ENCAPSULATED COSMETIC MATERIALS | DSMIP Assets B.V. (NL) | 2007-10-03 | — | — | EP | disclosed |
| US-20060153791-A1 | Repeat sequence protein polymer active agent congjugates, methods and uses | DANISCO US INC. | 2006-07-13 | — | — | US | disclosed |
| WO-2006061124-A1 | ENCAPSULATED COSMETIC MATERIALS | DSM IP ASSETS B.V. (NL) | 2006-06-15 | — | — | WO | disclosed |
| EP-1633382-A2 | REPEAT SEQUENCE PROTEIN POLYMER ACTIVE AGENT CONJUGATES, METHODS AND USES | Dow Corning Corporation (US) | 2006-03-15 | — | — | EP | disclosed |
| WO-2004104020-A2 | REPEAT SEQUENCE PROTEIN POLYMER ACTIVE AGENT CONJUGATES, METHODS AND USES | DOW CORNING CORPORATION (US) | 2004-12-02 | — | — | WO | disclosed |
| US-20040234609-A1 | Mixture of protein polymer and active material | GENENCOR INTERNATIONAL, INC. | 2004-11-25 | — | — | US | disclosed |
| US-20020098213-A1 | USE OF ELLAGIC ACID AND ITS DERIVATIVES IN COSMETICS AND DERMATOLOGY | LVMH RECHERCHE (FR) | 2002-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020098213-A1 | USE OF ELLAGIC ACID AND ITS DERIVATIVES IN COSMETICS AND DERMATOLOGY | COL1A1, CUTA, COL2A1 | TSHR 1972/4885TP53 2105/4885CYP3A4 3242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.